Note from Magdalena Lisiecka, Managing Director Janssen Poland

"The Janssen 4 Patients platform answers the needs of patients and the needs of system. As a company, we believe patients should be active participants."

Other in:

Note from Mira Armour, Patient Advocate Mijelom CRO, Croatia Advocacy Center
Note from Jana Pelouchova, Patient Advocate DIAGNOZA LEUKEMIA, Czechia Advocacy Center
Note from Vlatka Radić, Patient Engagement & Advocacy Lead, Janssen Central Eastern Europe Advocacy Center